Join us to enjoy these benefits

  • Late breaking clinical data
  • Presentations from past APSS meetings
  • APSS study groups
  • Indication-specific message boards
  • APSS event registration
  • Member polls
  • Case of the month
  • Patient education resource
July

PiperJaffray Analyst Report - IMAST Adds Color to Clouded Spine Debate

July 22, 2010  

Our take-aways from this year's IMAST meeting are not surprisingly less about new widgets and techniques and more about tone and trends in the spine market. Given the results and commentary from JNJ and SYK earlier in the week and the sell-off in ... Read More >>

June

SAS Journal Editorial - Value and cost in less invasive spinal fusion surgery: lessons from a community hospital

June 15, 2010  

Since MIS spine surgery appears to provide benefitsto the patients, is it truly cost effective?

We analyzed retrospectively the effect on costs seen at our institution (St. Mary’s Health Center, Jefferson, City, MO, a 160-bed communit... Read More >>

June

SAS Journal - Presacral retroperitoneal approach to axial lumbar interbody fusion: a new, minimally invasive technique at L5-S1: Clinical outcomes, complications, and fusion rates in 50 patients at 1-year follow-up

June 1, 2010  

Robert J. Bohinski, MD, PhD
Department of Neurosurgery, University of Cincinnati (UC) Neuroscience Institute, UC College of Medicine, Mayfield Clinic and Spine Institute, and The Christ Hospital, Cincinnati, OH

Viral V. Jain, MD
D... Read More >>

April

Orthopedics This Week - TranS1 Opens New Headquarters Dedicated to Research & Training

April 7, 2010  

By Walter Eisner

TranS1, Inc. opened its new corporate headquarters on March 30 in Wilmington,North Carolina. One of the state's U.S. Senators, Republican Richard Burr was on hand to cut the ribbon.

Read More >>

March

Journ. Neurosurg. Focus: Spine - Mid-term to long-term clinical and functional outcomes of minimally invasive correction and fusion for adults with scoliosis

March 1, 2010  

The attached reprint is inconsistent with indications for AxiaLIF® as cleared by FDA. The
cleared indications are as follows:

INDICATIONS and INTENDED USE: TranS1 AxiaLIF® System is intended to provide anterior stabilizati... Read More >>